Menu Back toHow to promote patient centricity ? - Based on experiences of clinician and head of regulatory agency

DIA EUROPE 2020


How to promote patient centricity ? - Based on experiences of clinician and head of regulatory agency

Session Chair(s)

Agnès  Saint-Raymond, DrMed

Agnès Saint-Raymond, DrMed

  • Head of Division International Affairs
  • European Medicines Agency, Netherlands
Junko  Sato, PhD

Junko Sato, PhD

  • Director, Office of International Programs
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Patient Centricity is becoming more important in pharmaceutical development and also in information sharing areas. In this session, heads of regulatory agencies share keys to patient centricity from their clinical and regulatory experiences.

Speaker(s)

Yasuhiro  Fujiwara, MD, PhD

Promoting Patient and Public Involvement in Japan

Yasuhiro Fujiwara, MD, PhD

  • Chief Executive
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Nathalie  Bere, MPH

Patient engagement, Public engagement Department, Stakeholders and Communication Division

Nathalie Bere, MPH

  • Patient Engagement
  • European Medicines Agency, Netherlands
Theresa  Mullin, PhD

Panelist

Theresa Mullin, PhD

  • Associate Director for Strategic Initiatives, CDER
  • FDA, United States